David A. Siegel Taro Pharmaceutical Industries LTD Transaction History

Two Sigma Advisers, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$32.77 - $42.31 $187,215 - $241,717	-5,713 Reduced 43.9%	7,300 $304,000
Q3 2023 Nov 14, 2023	BUY	$35.46 - $40.13 $461,440 - $522,211	13,013 New	13,013 $490,000
Q1 2020 May 15, 2020	SELL	$59.35 - $88.73 $302,685 - $452,523	-5,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.18 - $97.92 $81,598 - $107,712	1,100 Added 27.5%	5,100 $448,000
Q3 2019 Nov 14, 2019	SELL	$75.36 - $86.57 $7,536 - $8,657	-100 Reduced 2.44%	4,000 $302,000
Q2 2019 Aug 14, 2019	BUY	$83.92 - $108.88 $100,704 - $130,656	1,200 Added 41.38%	4,100 $350,000
Q1 2019 May 15, 2019	BUY	$85.97 - $108.09 $17,194 - $21,618	200 Added 7.41%	2,900 $313,000
Q4 2018 Feb 14, 2019	BUY	$78.25 - $107.92 $23,475 - $32,376	300 Added 12.5%	2,700 $229,000
Q3 2018 Nov 14, 2018	BUY	$97.82 - $116.09 $234,767 - $278,616	2,400 New	2,400 $236,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.